IONIS-MAPTRx

Promising Alzheimer’s drug utilizes ‘gene silencing’ breakthrough

First-ever trial of gene-silencing Alzheimer’s drug successfully lowers harmful tau protein, offering potential disease-altering effects. In a groundbreaking study led…

Read More »